Growing Leadership Recent hires of high-level executives such as the Chief Financial Officer and Chief Legal Officer indicate the company's strategic focus on strengthening leadership and operational capabilities, presenting opportunities to collaborate on financial planning and legal compliance solutions.

Market Engagement Participation in major healthcare conferences like the Needham Virtual Healthcare Conference and Guggenheim Securities SMID Cap Biotech Conference demonstrates an active effort to increase visibility and share innovative treatments, creating potential for partnerships and targeted outreach in the biopharmaceutical sector.

Patient Awareness Campaigns The launch of a direct-to-consumer advertising campaign for VOQUEZNA suggests strong marketing activity aimed at increasing product awareness and patient engagement, which could lead to opportunities for supporting marketing technology, analytics, and patient education initiatives.

Funding & Growth With significant funding of $90 million despite modest revenue levels, the company is positioned for expansion in R&D and commercialization efforts, offering avenues for sales of biotech infrastructure, laboratory solutions, and clinical trial support services.

Focus on GI Innovations Phathom’s commitment to transforming GI disease treatments signals ongoing demand for specialized medical solutions and partnerships in gastrointestinal health, opening opportunities with healthcare providers, hospitals, and specialty clinics for strategic collaborations.